Pictet Asset Management Sa Viking Therapeutics, Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 11,369 shares of VKTX stock, worth $563,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,369
Previous 11,369
-0.0%
Holding current value
$563,675
Previous $189,000
2.65%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
474Shares Held
66.2MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$504 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$299 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$232 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$105 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$93 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.8B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...